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the incidence of cachexia in the cats with and
without tumors that are being treated here.
Canine hemangiosarcoma: Clinicians are
examining the efficacy and toxicity of the
chemotherapy drug Doxil following surgery on
dogs with hemangiosarcoma, an aggressive
malignancy of blood vessels and the lining of
blood-filled spaces, most commonly the spleen.
Feline mammary tumor: This study evalu-
ates the role that reproductive/hormonal status
plays in the incidence of breast cancer in female
cats. In human and dog breast cancers, studies
show that reproductive/hormonal status is
important in the prognosis, prevention, and
treatment of disease. In dogs, a study similar
showed an increased risk of breast cancer corre-
lated with the age at which a dog was spayed. A
more recent study also showed that dogs spayed
around the time of diagnosis of mammary can-
cer enjoyed potentially improved survival rates
as well.
Canine melanoma: This study aims to
determine if the addition of chemotherapy to
the treatment of dogs with early-stage oral
melanoma (skin cancer) will improve survival
rates. Previous studies have evaluated treat-
ments of the primary tumor but have not
addressed treatment and prevention of micro-
scopic secondary tumors. Even with excellent
local treatment and no evidence of the spread
of cancer at diagnosis, most diagnosed dogs
(70–85%) still die from melanoma. (Prelimi-
nary results of this study indicated a positive
difference in overall survival.)
Magnetic resonance imaging of canine
splenic and liver lesions: The effectiveness of
MRI of the human spleen has been little stud-
ied due to the relative rarity of human splenic
lesions. In dogs, however, splenic lesions are rel-
atively common. Unfortunately, ultrasound, the
cross-sectional imaging modality most readily
available to veterinarians, cannot reliably differ-
entiate benign from malignant splenic and liver
lesions. In this prospective study, Oncology staff
will perform MRI examinations on dogs with
splenic and liver lesions that have been sched-
uled for surgery or biopsies. They seek to deter-
mine the MRI characteristics of these lesions
and to correlate MRI findings with pathologic
examination of the spleen, to better define the
effectiveness of MRI in determining the nature
of splenic and/or liver lesions in both dogs and
people. This study is funded via grants from the
Hospital of the University of Pennsylvania
(Radiology) and Ryan Clinical Research.
Canine lymphoma study: In human medi-
cine, it is well known that lymphoma is not a
solitary disease but a variety of disease, each
involving cancer of lymph cells. Treatment and
outcome are different according to sub-type. It
is also known that treatment of lymphoma
with chemotherapy can effectively wipe out
parts of the immune system for prolonged peri-
ods, which can affect a patient’s ability to fight
off infections and other cancers. This study will
better characterize the sub-types of malignant
lymph cells by flow cytometry and correlate the
results with standard classification schemes and
treatment outcome to establish new prognostic
markers in this disease. Flow cytometry is also
being used to characterize the circulating nor-
mal lymph cells to elucidate the role of the
patients’ immune system in maintaining remis-
sion. Thus, results will help us further under-
stand and eventually better treat this important
and relatively common canine cancer.
Evaluation of the cancer-prevention effects
of non-steroidal drug use in dogs: Results from
human studies show that chronic non-steroidal
anti-inflammatory drugs (NSAID) may prevent
or slow development of various types of cancer.
This preliminary study examines the chemo-
preventive effect of NSAID use in dogs, and
early results indicate that NSAID use may be
associated with decreased cancer risk in dogs.
Feline large granular lymphoma study:
Large granular lymphoma (LGL) is a rare vari-
ant of feline lymphoma. This study aims to
characterize clinical findings for cats diagnosed
with LGL. Results to date show that feline LGL
does not respond well to traditional surgical or
medical treatment, with survival times of only
45 days. Future studies include evaluation of
additional cases, determination of more effec-
tive treatments, and molecular characterization
of feline LGL cell types.
Treatment for canine malignant histiocytosis:
Canine malignant histocytosis/disseminate
histocytic sarcoma is a rare canine cancer with a
grave prognosis. No effect treatment is known.
A preliminary study determined that approxi-
mately 50 percent of diagnosed dogs respond to
the chemotherapeutic agent lomustine. Current
studies are under way to evaluate molecular
mechanisms of drug resistance in tumors that
do not respond to treatment.
These projects vary in scope and size and
affect both animals and humans. The ultimate
goal that underlies each study is finding out
more about cancer—and ultimately about
seeking its cure. In the meantime, while provid-
ing care to thousands of pets with cancer, the
Ryan Oncology team continues to add to the
body of knowledge that enhances our ability to
control this disease, evidence once again that
physicians and veterinarians are truly practicing 
“One Medicine” at Penn.
Editor’s note: For more information, visit
Oncolink, the Internet’s first cancer resource,
sponsored by Penn’s Abramson Cancer Center,
at <www.oncolink.upenn.edu>.
Annual SCAVMA Auction
The Student Chapter of the American
Veterinary Medical Association (SCAVMA)
will be holding its annual auction on Friday,
December 3, 2004, in the E. R. Marookian,
V.M.D. Auditorium at the Matthew J. Ryan
Veterinary Hospital of the University of
Pennsylvania.
Come, bid, and go home with new and
impressive items, ranging from home deco-
rations to exciting vacations. The event
begins with a silent auction at 3:00 p.m., fol-
lowed by a live auction at 5:00 p.m.
SCAVMA will also be selling Penn Veteri-
nary Medicine merchandise while other stu-
dent clubs will provide food and drinks.
Everyone is invited to support the auc-
tion! The SCAVMA auction is a popular
event for the entire School community and
benefits current students. Proceeds from the
silent auction defray the cost of student
travel to the annual National Student AVMA
Symposium. In addition, the live auction
proceeds help fund SCAVMA events and the
SCAVMA Scholarship Program, which
awards scholarships totaling $5,000 to stu-
dents based on their service to the School,
academic standing, and financial need.
The mission of SCAVMA is to increase
the quality of veterinary student life through
educational, social, and cultural extracurricu-
lar activities. Please help support this impor-
tant mission. For more information on the
auction or to donate auction items, contact
Shannon Omlor, V’07, Auction Co-Chairper-
son, via email at somlor@vet.upenn.edu.
